Zura Bio Ltd. (ZURA) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Zura Bio Ltd. (ZURA:NASDAQ), powered by AI.

Current Price
$3.52
P/E Ratio
-4.8
Market Cap
331M
Sector
Healthcare
What is the Zura Bio Ltd. stock price forecast?

Zura Bio Ltd. is currently trading at $3.52. View real-time AI analysis on Alpha Lenz.

What is Zura Bio Ltd. insider trading activity?

View the latest insider trading data for Zura Bio Ltd. on Alpha Lenz.

What is Zura Bio Ltd.'s P/E ratio?

Zura Bio Ltd.'s P/E ratio is -4.8.

Zura Bio Ltd.

NASDAQ · ZURA
$3.52-0.17(-4.48%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Zura Bio Ltd.'s future dividend policy...
Alpha Chat Insight

Zura Bio Ltd. trades at a P/E of -4.8 (undervalued) with modest ROE of -55.3%.

Ask for details

Company Overview

Zura Bio Ltd. is a crucial player in the biotechnology sector, specializing in the development of innovative therapeutics targeting immune disorders and other critical diseases. The primary focus of Zura Bio is to create pioneering drugs and treatment protocols that enhance patient outcomes, particularly for conditions that currently have limited treatment options. Its contributions are significant in the pharmaceutical and healthcare industries, where ongoing research and development are key to addressing unmet medical needs. Within the financial markets, Zura Bio attracts attention from investors and analysts due to its potential for groundbreaking advancements and its role in the growing biopharma space. The company's operations might also influence sectors like healthcare equipment and supply chain management, as new treatments can drive demand for related medical services and products. Overall, Zura Bio Ltd. plays a pivotal role in advancing medical research and improving quality of life through its commitment to biotechnological innovation.

CEOMr. Robert Lisicki
SectorHealthcare
IndustryBiotechnology
Employees30

Company Statistics

FY 2025

Profile

$330.97MMarket Cap
$0.00Revenue
0.00Shares Out
30Employees

Margins

N/AGross
N/AEBITDA
N/AOperating
N/APre-Tax
N/ANet

Valuation

-4.82P/E
3.26P/B
N/AEV/Sales
-2.95EV/EBITDA
-5.10P/FCF

Growth (CAGR)

N/ARev 3Yr
N/ARev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-46.78%ROA
-55.28%ROE
-51.28%ROIC

Financial Health

$109.41MCash & Cash Equivalents
$-97.00MNet Debt
12.22%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Zura Bio Ltd. (ticker: ZURA) is a company listed on NASDAQ in the Healthcare sector (Biotechnology). It has approximately 30 employees. Market cap is $331M.

The current price is $3.515 with a P/E ratio of -4.82x and P/B of 3.26x.

ROE is -55.28%.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Zura Bio Ltd. (ZURA) Stock Forecast 2026 $3.52 — Price, Financials & Analyst Targets | Alpha Lenz